Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) EPS (Basic): 2018-2022

Historic EPS (Basic) for ADC Therapeutics (ADCT) over the last 5 years, with Dec 2022 value amounting to -$0.00.

  • ADC Therapeutics' EPS (Basic) fell 187.69% to -$0.57 in Q3 2023 from the same period last year, while for Sep 2023 it was -$0.43, marking a year-over-year decrease of 134.15%. This contributed to the annual value of -$0.00 for FY2022, which is 99.94% up from last year.
  • ADC Therapeutics' EPS (Basic) amounted to -$0.00 in FY2022, which was up 99.94% from -$3 recorded in FY2021.
  • In the past 5 years, ADC Therapeutics' EPS (Basic) registered a high of -$0.00 during FY2022, and its lowest value of -$3.77 during FY2020.
  • For the 3-year period, ADC Therapeutics' EPS (Basic) averaged around -$2.26, with its median value being -$3 (2021).
  • In the last 5 years, ADC Therapeutics' EPS (Basic) tumbled by 59.75% in 2020 and then skyrocketed by 99.94% in 2022.
  • Yearly analysis of 5 years shows ADC Therapeutics' EPS (Basic) stood at -$2.64 in 2018, then rose by 10.61% to -$2.36 in 2019, then plummeted by 59.75% to -$3.77 in 2020, then climbed by 20.42% to -$3 in 2021, then spiked by 99.94% to -$0.00 in 2022.